IMI launches ADAPT SMART

The Innovative Medicines Initiative launched a new project Friday titled "Accelerated Development of Appropriate Patient Therapies: a Sustainable, Multi-stakeholder Approach from Research to Treatment-outcomes" (ADAPT SMART).

The aim of the public-private partnership is to develop Medicines Adaptive Pathways to Patients (MAPPs) that would allow researchers, regulators and reimbursement authorities to gather, evaluate and act upon new evidence for therapies that are approved with limited safety and efficacy data via mechanisms like EMA's Adaptive Licensing pathway. ...